Contact

All Stories

  1. Upregulated Retinal Neurofilament Expression in Experimental Optic Neuritis

    Article • Neuro-Ophthalmology, January 2022, Taylor & Francis

    Mr axel petzold

  2. Automated Pupillometry Using a Prototype Binocular Optical Coherence Tomography System

    Article • American Journal of Ophthalmology, June 2020, Elsevier

    Mr axel petzold

  3. Blocked Eye-Brain connection in Multiple Sclerosis

    Article • Annals of Neurology, May 2020, Wiley

    Mr axel petzold

  4. Protein aggregate formation permits millennium-old brain preservation

    Article • Journal of The Royal Society Interface, January 2020, Royal Society Publishing

    Mr axel petzold

  5. Time is Vision

    Article • Journal of Neurology Neurosurgery & Psychiatry, November 2019, BMJ

    Mr axel petzold

  6. Progression of Anterograde Trans-Synaptic Degeneration in the Human Retina Is Modulated by Axonal Convergence and Divergence

    Article • Neuro-Ophthalmology, May 2019, Taylor & Francis

    Mr axel petzold

  7. Aquaporin-4 and myelin oligodendrocyte glycoprotein antibodies in immune-mediated optic neuritis at long-term follow-up

    Article • Journal of Neurology Neurosurgery & Psychiatry, May 2019, BMJ

    Mr axel petzold

  8. Quantile regression analysis reveals widespread evidence for gene-environment or gene-gene interactions in myopia development

    Article • Communications Biology, May 2019, Springer Science + Business Media

    Mr axel petzold

  9. Optimal intereye difference thresholds by optical coherence tomography in multiple sclerosis: An international study

    Article • Annals of Neurology, April 2019, Wiley

    Mr axel petzold

  10. Quantification of Visual Fixation in Multiple Sclerosis

    Article • Investigative Ophthalmology & Visual Science, April 2019, Association for Research in Vision and Ophthalmology (ARVO)

    Mr axel petzold

  11. A 30 s test for quantitative assessment of a relative afferent pupillary defect (RAPD): the infrared pupillary asymmetry (IPA)

    Article • Journal of Neurology, February 2019, Springer Science + Business Media

    Mr axel petzold

  12. Treatment of internuclear ophthalmoparesis in multiple sclerosis with fampridine: A randomized double‐blind, placebo‐controlled cross‐over trial

    Article • CNS Neuroscience & Therapeutics, February 2019, Wiley

    Mr axel petzold

  13. The relevance of buffer system ionic strength in immunoassay development

    Article • Journal of Immunological Methods, February 2019, Elsevier

    Mr axel petzold

  14. The prognostic value of neurofilament levels in patients with sepsis-associated encephalopathy – A prospective, pilot observational study

    Article • PLoS ONE, January 2019, PLOS

    Mr axel petzold

  15. An ontological foundation for ocular phenotypes and rare eye diseases

    Article • Orphanet Journal of Rare Diseases, January 2019, Springer Science + Business Media

    Mr axel petzold

  16. Peripapillary Hyperreflective Ovoid Mass-Like Structures

    Article • Journal of Neuro-Ophthalmology, December 2018, Wolters Kluwer Health

    Mr axel petzold

  17. The International Multiple Sclerosis Visual System Consortium

    Article • Journal of Neuro-Ophthalmology, December 2018, Wolters Kluwer Health

    Mr axel petzold

  18. Association of Retinal Nerve Fiber Layer Thinning With Current and Future Cognitive Decline

    Article • JAMA Neurology, October 2018, American Medical Association (AMA)

    Mr axel petzold

  19. The role of optical coherence tomography and infrared oculography in assessing the visual pathway and CNS in multiple sclerosis

    Article • Neurodegenerative Disease Management, September 2018, Future Medicine

    Mr axel petzold

  20. A motor neuron strategy to save time and energy in neurodegeneration: adaptive protein stoichiometry

    Article • Journal of Neurochemistry, September 2018, Wiley

    Mr axel petzold

  21. Treating the Eyes to Help the Brain

    Article • JAMA Ophthalmology, September 2018, American Medical Association (AMA)

    Mr axel petzold

  22. Neurofilaments as biomarkers in neurological disorders

    Article • Nature Reviews Neurology, August 2018, Springer Science + Business Media

    Mr axel petzold

  23. A standardized protocol for quantification of saccadic eye movements: DEMoNS

    Article • PLoS ONE, July 2018, PLOS

    Mr axel petzold

  24. Neuro-ophthalmic literature review

    Article • Neuro-Ophthalmology, July 2018, Taylor & Francis

    Mr axel petzold

  25. Applying the 2017 McDonald diagnostic criteria for multiple sclerosis

    Article • The Lancet Neurology, June 2018, Elsevier

    Mr axel petzold

  26. The Pulfrich phenomenon: Practical implications of the assessment of cases and effectiveness of treatment

    Article • Neuro-Ophthalmology, April 2018, Taylor & Francis

    Mr axel petzold

  27. Software updates of OCT segmentation algorithms influence longitudinal assessment of retinal atrophy

    Article • Journal of the Neurological Sciences, April 2018, Elsevier

    Mr axel petzold

  28. Identification and treatment of the visual processing asymmetry in MS patients with optic neuritis: The Pulfrich phenomenon

    Article • Journal of the Neurological Sciences, April 2018, Elsevier

    Mr axel petzold

  29. Multicenter reliability of semiautomatic retinal layer segmentation using OCT

    Article • Neurology Neuroimmunology & Neuroinflammation, March 2018, Wolters Kluwer Health

    Mr axel petzold

  30. Retinal optical coherence tomography shows optic disc changes in low intracranial pressure headaches: a case report

    Article • Acta Neurologica Belgica, January 2018, Springer Science + Business Media

    Mr axel petzold

  31. Reply to the letter by Jasmin Zvorničanin on the article Prefoveal floaters as a differential diagnosis to optic neuritis: “mouches dormantes”

    Article • Acta Neurologica Belgica, November 2017, Springer Science + Business Media

    Mr axel petzold

  32. Translational evidence for two distinct patterns of neuroaxonal injury in sepsis: a longitudinal, prospective translational study

    Article • Critical Care, October 2017, Springer Science + Business Media

    Mr axel petzold

  33. Diagnostic accuracy of optical coherence tomography inter-eye percentage difference for optic neuritis in multiple sclerosis

    Article • European Journal of Neurology, October 2017, Wiley

    Mr axel petzold

  34. The Optic Disc Drusen Studies Consortium Recommendations for Diagnosis of Optic Disc Drusen Using Optical Coherence Tomography

    Article • Journal of Neuro-Ophthalmology, October 2017, Wolters Kluwer Health

    Mr axel petzold

  35. Time is vision in recurrent optic neuritis

    Article • Brain Research, October 2017, Elsevier

    Mr axel petzold

  36. Retinal layer segmentation in multiple sclerosis: a systematic review and meta-analysis

    Article • The Lancet Neurology, October 2017, Elsevier

    Mr axel petzold

  37. Biomarkers of Disease Progression

    Article • August 2017, Springer Science + Business Media

    Mr axel petzold

  38. Volume rendering of superficial optic disc drusen

    Article • Spektrum der Augenheilkunde, August 2017, Springer Science + Business Media

    Mr axel petzold

  39. Structure-function relationships in the visual system in multiple sclerosis: an MEG and OCT study

    Article • Annals of Clinical and Translational Neurology, July 2017, Wiley

    Mr axel petzold

  40. Prefoveal floaters as a differential diagnosis to optic neuritis: “mouches dormantes”

    Article • Acta Neurologica Belgica, June 2017, Springer Science + Business Media

    Mr axel petzold

  41. Retinal atrophy in relation to visual functioning and vision-related quality of life in patients with multiple sclerosis

    Article • Multiple Sclerosis Journal, May 2017, SAGE Publications

    Mr axel petzold

  42. Case 3-2017: A Man with Cardiac Sarcoidosis and New Diplopia and Weakness

    Article • New England Journal of Medicine, May 2017, New England Journal of Medicine (NEJM/MMS)

    Mr axel petzold

  43. Optical coherence tomography angiography and retinal microvascular ramification in acute macular neuroretinopathy and paracentral acute middle maculopathy

    Article • Survey of Ophthalmology, May 2017, Elsevier

    Mr axel petzold

  44. A rare cause for visual symptoms in multiple sclerosis: posterior internuclear ophthalmoplegia of Lutz, a historical misnomer

    Article • Journal of Neurology, February 2017, Springer Science + Business Media

    Mr axel petzold

  45. Cognitive impairment in patients with multiple sclerosis is associated with atrophy of the inner retinal layers

    Article • Multiple Sclerosis Journal, February 2017, SAGE Publications

    Mr axel petzold

  46. Neuroprotection and visual function after optic neuritis

    Article • Current Opinion in Neurology, February 2017, Wolters Kluwer Health

    Mr axel petzold

  47. Serum Compounds of Energy Metabolism Impairment Are Related to Disability, Disease Course and Neuroimaging in Multiple Sclerosis

    Article • Molecular Neurobiology, November 2016, Springer Science + Business Media

    Mr axel petzold

  48. Retinal glymphatic system: an explanation for transient retinal layer volume changes?

    Article • Brain, October 2016, Oxford University Press (OUP)

    Mr axel petzold

  49. An early case of a natural barrier to axonal degeneration

    Article • Deutsche Zeitschrift für Nervenheilkunde, October 2016, Springer Science + Business Media

    Mr axel petzold

  50. Elevated CSF neurofilament proteins predict brain atrophy: A 15-year follow-up study

    Article • Multiple Sclerosis Journal, July 2016, SAGE Publications

    Mr axel petzold

  51. The APOSTEL recommendations for reporting quantitative optical coherence tomography studies

    Article • Neurology, May 2016, Wolters Kluwer Health

    Mr axel petzold

  52. Timing of retinal neuronal and axonal loss in MS: a longitudinal OCT study

    Article • Journal of Neurology, May 2016, Springer Science + Business Media

    Mr axel petzold

  53. Retinal thickness measured with optical coherence tomography and risk of disability worsening in multiple sclerosis: a cohort study

    Article • The Lancet Neurology, May 2016, Elsevier

    Mr axel petzold

  54. Plasma neurofilament heavy chain is not a useful biomarker in Charcot-Marie-Tooth disease

    Article • Muscle & Nerve, April 2016, Wiley

    Mr axel petzold

  55. Autoimmunity in visual loss

    Article • January 2016, Elsevier

    Mr axel petzold

  56. Elevated vitreous body glial fibrillary acidic protein in retinal diseases

    Article • Graefe s Archive for Clinical and Experimental Ophthalmology, August 2015, Springer Science + Business Media

    Mr axel petzold

  57. The prevalence of microcystic macular changes on optical coherence tomography of the macular region in optic nerve atrophy of non-neuritis origin: a prospective study

    Article • British Journal of Ophthalmology, June 2015, BMJ

    Mr axel petzold

  58. Neurofilament light chain: A prognostic biomarker in amyotrophic lateral sclerosis

    Article • Neurology, May 2015, Wolters Kluwer Health

    Mr axel petzold

  59. Cerebral Salt Wasting Syndrome

    Article • New England Journal of Medicine, March 2015, New England Journal of Medicine (NEJM/MMS)

    Mr axel petzold

  60. Pain in Optic Perineuritis: Author Response

    Article • Neuro-Ophthalmology, March 2015, Taylor & Francis

    Mr axel petzold

  61. Glial fibrillary acidic protein is a body fluid biomarker for glial pathology in human disease

    Article • Brain Research, March 2015, Elsevier

    Mr axel petzold

  62. The prognostic value of CSF neurofilaments in multiple sclerosis at 15-year follow-up

    Article • Journal of Neurology Neurosurgery & Psychiatry, January 2015, BMJ

    Mr axel petzold

  63. Neuro-Ophthalmic Literature Review

    Article • Neuro-Ophthalmology, January 2015, Taylor & Francis

    Mr axel petzold

  64. Diagnostic clues and manifesting carriers in fukutin-related protein (FKRP) limb-girdle muscular dystrophy

    Article • Journal of the Neurological Sciences, January 2015, Elsevier

    Mr axel petzold

  65. The impact of Tween 20 on repeatability of amyloid β and tau measurements in cerebrospinal fluid

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), January 2015, De Gruyter

    Mr axel petzold

  66. Visual pathway neurodegeneration winged by mitochondrial dysfunction

    Article • Annals of Clinical and Translational Neurology, December 2014, Wiley

    Mr axel petzold

  67. Re: Garcia-Martin et al.: Retinal layer segmentation in patients with multiple sclerosis using spectral domain optical coherence tomography (Ophthalmology 2014;121:573–9)

    Article • Ophthalmology, November 2014, Elsevier

    Mr axel petzold

  68. Distribution of Retinal Layer Atrophy in Patients With Parkinson Disease and Association With Disease Severity and Duration

    Article • American Journal of Ophthalmology, October 2014, Elsevier

    Mr axel petzold

  69. Neuro-Ophthalmic Literature Review

    Article • Neuro-Ophthalmology, September 2014, Taylor & Francis

    Mr axel petzold

  70. Physiological variation of retinal layer thickness is not caused by hydration: A randomised trial

    Article • Journal of the Neurological Sciences, September 2014, Elsevier

    Mr axel petzold

  71. Retinal Segmentation to Demonstrate Hyperplasia in Ataxia of Charlevoix-Saguenay: Critique on Study Methodology and Results

    Article • Investigative Ophthalmology & Visual Science, August 2014, Association for Research in Vision and Ophthalmology (ARVO)

    Mr axel petzold

  72. Plasma neurofilament heavy chain levels and disease progression in amyotrophic lateral sclerosis: insights from a longitudinal study

    Article • Journal of Neurology Neurosurgery & Psychiatry, July 2014, BMJ

    Mr axel petzold

  73. The investigation of acute optic neuritis: a review and proposed protocol

    Article • Nature Reviews Neurology, July 2014, Springer Science + Business Media

    Mr axel petzold

  74. Effects of Repeated Intrathecal Triamcinolone-Acetonide Application on Cerebrospinal Fluid Biomarkers of Axonal Damage and Glial Activity in Multiple Sclerosis Patients

    Article • Molecular Diagnosis & Therapy, July 2014, Springer Science + Business Media

    Mr axel petzold

  75. Serum lactate as a novel potential biomarker in multiple sclerosis

    Article • Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, July 2014, Elsevier

    Mr axel petzold

  76. Bidirectional trans-synaptic axonal degeneration in the visual pathway in multiple sclerosis

    Article • Journal of Neurology Neurosurgery & Psychiatry, June 2014, BMJ

    Mr axel petzold

  77. Quality control for retinal OCT in multiple sclerosis: validation of the OSCAR-IB criteria

    Article • Multiple Sclerosis Journal, June 2014, SAGE Publications

    Mr axel petzold

  78. Serum neurofilament light chain is a biomarker of human spinal cord injury severity and outcome

    Article • Journal of Neurology Neurosurgery & Psychiatry, June 2014, BMJ

    Mr axel petzold

  79. Neuro-Ophthalmic Literature Review

    Article • Neuro-Ophthalmology, May 2014, Taylor & Francis

    Mr axel petzold

  80. Cerebrospinal fluid transferrin levels are reduced in patients with early multiple sclerosis

    Article • Multiple Sclerosis Journal, April 2014, SAGE Publications

    Dr Stefan Ropele, Mr axel petzold

  81. Diagnosis and classification of autoimmune optic neuropathy

    Article • Autoimmunity Reviews, April 2014, Elsevier

    Mr axel petzold

  82. Current and future potential of retinal optical coherence tomography in multiple sclerosis with and without optic neuritis

    Article • Neurodegenerative Disease Management, April 2014, Future Medicine

    Mr axel petzold

  83. Neurofilament heavy chain as a marker of neuroaxonal pathology and prognosis in acute encephalitis

    Article • European Journal of Neurology, March 2014, Wiley

    Mr axel petzold

  84. Serum phosphorylated neurofilament-heavy chain levels in multiple sclerosis patients

    Article • Journal of Neurology Neurosurgery & Psychiatry, March 2014, BMJ

    Professor Anthony W Purcell, Mr axel petzold

  85. Neuro-Ophthalmic Literature Review

    Article • Neuro-Ophthalmology, March 2014, Taylor & Francis

    Mr axel petzold

  86. Recurrent Optic Perineuritis after Intranasal Cocaine Abuse

    Article • Neuro-Ophthalmology, February 2014, Taylor & Francis

    Mr axel petzold

  87. Biomarker time out

    Article • Multiple Sclerosis Journal, February 2014, SAGE Publications

    Mr axel petzold

  88. The Clinical Spectrum of Microcystic Macular Edema

    Article • Investigative Ophthalmology & Visual Science, February 2014, Association for Research in Vision and Ophthalmology (ARVO)

    Mr axel petzold

  89. A dam for retrograde axonal degeneration in multiple sclerosis?

    Article • Journal of Neurology Neurosurgery & Psychiatry, January 2014, BMJ

    Mr axel petzold

  90. Disease course heterogeneity and OCT in multiple sclerosis

    Article • Multiple Sclerosis Journal, January 2014, SAGE Publications

    Mr axel petzold

  91. Retinal hyperaemia-related blood vessel artifacts are relevant to automated OCT layer segmentation

    Article • Deutsche Zeitschrift für Nervenheilkunde, January 2014, Springer Science + Business Media

    Mr axel petzold

  92. Neurofilaments as a plasma biomarker for ICU-acquired weakness: an observational pilot study

    Article • Critical Care, January 2014, Springer Science + Business Media

    Mr axel petzold

  93. Neurodegeneration and Multiple Sclerosis

    Article • January 2014, Springer Science + Business Media

    Mr axel petzold

  94. Optical Coherence Tomography to Assess Neurodegeneration in Multiple Sclerosis

    Article • January 2014, Springer Science + Business Media

    Mr axel petzold

  95. Optic Neuritis: Another Dickensian Diagnosis

    Article • Neuro-Ophthalmology, November 2013, Taylor & Francis

    Mr axel petzold

  96. Chronic Lymphocytic Inflammation With Pontine Perivascular Enhancement Responsive to Steroids and Fatal B-Cell Lymphoma—Reply

    Article • JAMA Neurology, November 2013, American Medical Association (AMA)

    Mr axel petzold

  97. Physiological variation of segmented OCT retinal layer thicknesses is short-lasting

    Article • Journal of Neurology, October 2013, Springer Science + Business Media

    Mr axel petzold

  98. Increased Neurofilament Light Chain Blood Levels in Neurodegenerative Neurological Diseases

    Article • PLoS ONE, September 2013, PLOS

    Mr axel petzold

  99. Should CLIPPERS Be Considered a Prelymphoma State or a New Inflammatory Disease?—Reply

    Article • JAMA Neurology, September 2013, American Medical Association (AMA)

    Mr axel petzold

  100. Intrathecal oligoclonal IgG synthesis in multiple sclerosis

    Article • Journal of Neuroimmunology, September 2013, Elsevier

    Mr axel petzold

  101. Pain Management in Neurocritical Care

    Article • Neurocritical Care, July 2013, Springer Science + Business Media

    Mr axel petzold

  102. Fatal B-cell Lymphoma Following Chronic Lymphocytic Inflammation With Pontine Perivascular Enhancement Responsive to Steroids

    Article • JAMA Neurology, July 2013, American Medical Association (AMA)

    Mr axel petzold

  103. Optical Coherence Tomography Reveals Distinct Patterns of Retinal Damage in Neuromyelitis Optica and Multiple Sclerosis

    Article • PLoS ONE, June 2013, PLOS

    Mr axel petzold

  104. Serial cerebrospinal fluid neurofilament heavy chain levels in severe Guillain-Barré syndrome

    Article • Muscle & Nerve, May 2013, Wiley

    Mr axel petzold

  105. Chronic relapsing inflammatory optic neuropathy: a systematic review of 122 cases reported

    Article • Journal of Neurology, May 2013, Springer Science + Business Media

    Mr axel petzold

  106. Influence of the Eye-Tracking–Based Follow-Up Function in Retinal Nerve Fiber Layer Thickness Using Fourier-Domain Optical Coherence Tomography

    Article • Investigative Ophthalmology & Visual Science, April 2013, Association for Research in Vision and Ophthalmology (ARVO)

    Mr axel petzold

  107. Patterns of non-embolic transient monocular visual field loss

    Article • Journal of Neurology, April 2013, Springer Science + Business Media

    Mr axel petzold

  108. The utility of cerebrospinal fluid analysis in patients with multiple sclerosis

    Article • Nature Reviews Neurology, March 2013, Springer Science + Business Media

    Mr axel petzold

  109. Loss of retinal nerve fibre layer axons indicates white but not grey matter damage in early multiple sclerosis

    Article • European Journal of Neurology, January 2013, Wiley

    Mr axel petzold

  110. Cerebrospinal fluid analyses for the diagnosis of subarachnoid haemorrhage and experience from a Swedish study. What method is preferable when diagnosing a subarachnoid haemorrhage?

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), January 2013, De Gruyter

    Mr axel petzold

  111. Embolic and Nonembolic Transient Monocular Visual Field Loss: A Clinicopathologic Review

    Article • Survey of Ophthalmology, January 2013, Elsevier

    Mr axel petzold

  112. A Simple Sign for Recognizing Off–Axis OCT Measurement Beam Placement in the Context of Multicentre Studies

    Article • PLoS ONE, November 2012, PLOS

    Mr axel petzold

  113. Microcystic macular oedema in MS: T2 lesion or black hole?

    Article • The Lancet Neurology, November 2012, Elsevier

    Mr axel petzold

  114. Comment on "Chronic Traumatic Encephalopathy in Blast-Exposed Military Veterans and a Blast Neurotrauma Mouse Model"

    Article • Science Translational Medicine, October 2012, American Association for the Advancement of Science

    Mr axel petzold

  115. Microcystic macular oedema confirmed, but not specific for multiple sclerosis

    Article • Brain, October 2012, Oxford University Press (OUP)

    Mr axel petzold

  116. Plasma Neurofilament Heavy Chain Levels Correlate to Markers of Late Stage Disease Progression and Treatment Response in SOD1G93A Mice that Model ALS

    Article • PLoS ONE, July 2012, PLOS

    Mr axel petzold

  117. Recurrent Laughter-induced Syncope

    Article • The Neurologist, July 2012, Wolters Kluwer Health

    Mr axel petzold

  118. Biomarkers of Disease Progression

    Article • June 2012, Springer Science + Business Media

    Mr axel petzold

  119. Serum GFAP levels in optic neuropathies

    Article • Journal of the Neurological Sciences, June 2012, Elsevier

    Mr axel petzold

  120. Glial S100B is elevated in serum across the spectrum of west nile virus infection

    Article • Muscle & Nerve, May 2012, Wiley

    Mr axel petzold

  121. The OSCAR-IB Consensus Criteria for Retinal OCT Quality Assessment

    Article • PLoS ONE, April 2012, PLOS

    Mr axel petzold

  122. Neurofilament heavy chain and heat shock protein 70 as markers of seizure-related brain injury

    Article • Epilepsia, April 2012, Wiley

    Mr axel petzold

  123. The Physiological Variation of the Retinal Nerve Fiber Layer Thickness and Macular Volume in Humans as Assessed by Spectral Domain–Optical Coherence Tomography

    Article • Investigative Ophthalmology & Visual Science, March 2012, Association for Research in Vision and Ophthalmology (ARVO)

    Mr axel petzold

  124. Roadmap and standard operating procedures for biobanking and discovery of neurochemical markers in ALS

    Article • Amyotrophic Lateral Sclerosis, January 2012, Taylor & Francis

    Mr axel petzold

  125. The Diagnostic and Prognostic Value of Neurofilament Heavy Chain Levels in Immune-Mediated Optic Neuropathies

    Article • Multiple Sclerosis International, January 2012, Hindawi Publishing Corporation

    Mr axel petzold

  126. Serial soluble neurofilament heavy chain in plasma as a marker of brain injury after cardiac arrest

    Article • Critical Care, January 2012, Springer Science + Business Media

    Mr axel petzold

  127. Anti-voltage-gated potassium channel Kv1.4 antibodies in myasthenia gravis

    Article • Journal of Neurology, December 2011, Springer Science + Business Media

    Mr axel petzold

  128. Axonal damage in the making: Neurofilament phosphorylation, proton mobility and magnetisation transfer in multiple sclerosis normal appearing white matter

    Article • Experimental Neurology, December 2011, Elsevier

    Mr axel petzold

  129. Cerebrospinal Fluid Ferritin Level, a Sensitive Diagnostic Test in Late-Presenting Subarachnoid Hemorrhage

    Article • Journal of Stroke and Cerebrovascular Diseases, November 2011, Elsevier

    Mr axel petzold

  130. The Prognostic Value of Brain Extracellular Fluid Nitric Oxide Metabolites After Traumatic Brain Injury

    Article • Neurocritical Care, October 2011, Springer Science + Business Media

    Mr axel petzold

  131. Erratum to: Rostrocaudal Dynamics of CSF Biomarkers

    Article • Neurochemical Research, October 2011, Springer Science + Business Media

    Mr axel petzold

  132. Disease-Specific Cerebrospinal Fluid Investigations

    Article • September 2011, Wiley

    Mr axel petzold

  133. The Use of Serum Glial Fibrillary Acidic Protein Measurements in the Diagnosis of Neuromyelitis Optica Spectrum Optic Neuritis

    Article • PLoS ONE, August 2011, PLOS

    Mr axel petzold

  134. Soluble Beta-Amyloid Precursor Protein Is Related to Disease Progression in Amyotrophic Lateral Sclerosis

    Article • PLoS ONE, August 2011, PLOS

    Mr axel petzold

  135. Neurofilament stoichiometry simulations during neurodegeneration suggest a remarkable self-sufficient and stable in vivo protein structure

    Article • Journal of the Neurological Sciences, August 2011, Elsevier

    Mr axel petzold

  136. Hyperacute Detection of Neurofilament Heavy Chain in Serum Following Stroke: A Transient Sign

    Article • Neurochemical Research, July 2011, Springer Science + Business Media

    Mr axel petzold

  137. Cognitive, biochemical, and imaging profile of patients suffering from idiopathic normal pressure hydrocephalus

    Article • Alzheimer s & Dementia, July 2011, Wiley

    Mr axel petzold

  138. Exceptional preservation of a prehistoric human brain from Heslington, Yorkshire, UK

    Article • Journal of Archaeological Science, July 2011, Elsevier

    Mr axel petzold

  139. What makes a prognostic biomarker in CNS diseases: strategies for targeted biomarker discovery? Part 2: chronic progressive and relapsing disease

    Article • Expert Opinion on Medical Diagnostics, June 2011, Informa Healthcare

    Mr axel petzold

  140. Normal CSF ferritin levels in MS suggest against etiologic role of chronic venous insufficiency

    Article • Neurology, June 2011, Wolters Kluwer Health

    Ms Sena Jeong, Mr axel petzold

  141. The neurofilament light chain is not stable in vitro

    Article • Annals of Neurology, June 2011, Wiley

    Mr axel petzold

  142. Reply

    Article • Annals of Neurology, June 2011, Wiley

    Mr axel petzold

  143. What makes a prognostic biomarker in CNS diseases: strategies for targeted biomarker discovery? Part 1: acute and monophasic diseases

    Article • Expert Opinion on Medical Diagnostics, May 2011, Informa Healthcare

    Mr axel petzold

  144. Neurofilament heavy chain in CSF correlates with relapses and disability in multiple sclerosis

    Article • Neurology, February 2011, Wolters Kluwer Health

    Mr axel petzold, Prof Daniel C Anthony

  145. Remote Ischemic Preconditioning Protects the Brain Against Injury After Hypothermic Circulatory Arrest

    Article • Circulation, February 2011, Wolters Kluwer Health

    Mr axel petzold

  146. A method to solubilise protein aggregates for immunoassay quantification which overcomes the neurofilament “hook” effect

    Article • Journal of Neuroscience Methods, February 2011, Elsevier

    Mr axel petzold

  147. In vivo monitoring of neuronal loss in traumatic brain injury: a microdialysis study

    Article • Brain, January 2011, Oxford University Press (OUP)

    Mr axel petzold

  148. International Issues: The EAYNT: Ten years of unifying European junior neurologists

    Article • Neurology, January 2011, Wolters Kluwer Health

    Mr axel petzold

  149. Neurodegeneration in MS and NMO: The Eye and the Blood

    Article • Multiple Sclerosis International, January 2011, Hindawi Publishing Corporation

    Mr axel petzold, Professor Robert Weissert

  150. Matrix Metalloproteinases in Myasthenia Gravis

    Article • European Neurology, January 2011, Karger Publishers

    Mr axel petzold

  151. Consensus Guidelines for CSF and Blood Biobanking for CNS Biomarker Studies

    Article • Multiple Sclerosis International, January 2011, Hindawi Publishing Corporation

    Mr axel petzold

  152. Blood and CSF Biomarker Dynamics in Multiple Sclerosis: Implications for Data Interpretation

    Article • Multiple Sclerosis International, January 2011, Hindawi Publishing Corporation

    Mr axel petzold

  153. Rostrocaudal Dynamics of CSF Biomarkers

    Article • Neurochemical Research, December 2010, Springer Science + Business Media

    Mr axel petzold

  154. Evidence for acute neurotoxicity after chemotherapy

    Article • Annals of Neurology, December 2010, Wiley

    Mr axel petzold

  155. Batch prepared protein standards for cerebrospinal fluid (CSF) biomarkers for neurodegeneration

    Article • Journal of Neuroscience Methods, November 2010, Elsevier

    Mr axel petzold

  156. Ocular Flutter Following Adenoviral Conjunctivitis in an Adult

    Article • Neuro-Ophthalmology, October 2010, Taylor & Francis

    Mr axel petzold

  157. Normal CSF ferritin levels in MS suggest against etiologic role of chronic venous insufficiency

    Article • Neurology, September 2010, Wolters Kluwer Health

    Mr axel petzold

  158. Optical coherence tomography in multiple sclerosis: a systematic review and meta-analysis

    Article • The Lancet Neurology, September 2010, Elsevier

    Mr axel petzold

  159. Anti-Heat Shock Protein 70 antibody levels are increased in myasthenia gravis and Guillain-Barré syndrome

    Article • Journal of Neuroimmunology, August 2010, Elsevier

    Mr axel petzold

  160. Glial but not axonal protein biomarkers as a new supportive diagnostic criteria for Devic neuromyelitis optica? Preliminary results on 188 patients with different neurological diseases

    Article • Journal of Neurology Neurosurgery & Psychiatry, July 2010, BMJ

    Mr axel petzold

  161. Urinary neopterin and nitric oxide metabolites as markers of interferon β-1a activity in primary progressive multiple sclerosis

    Article • Multiple Sclerosis Journal, July 2010, SAGE Publications

    Mr axel petzold

  162. Differential pattern of brain-specific CSF proteins tau and amyloid-beta in Parkinsonian syndromes

    Article • Movement Disorders, June 2010, Wiley

    Mr axel petzold

  163. An unbiased, staged, multicentre, validation strategy for Alzheimer's disease CSF tau levels

    Article • Experimental Neurology, June 2010, Elsevier

    Mr axel petzold

  164. Liquordiagnostik bei CT-negativer Subarachnoidalblutung

    Article • Der Nervenarzt, April 2010, Springer Science + Business Media

    Mr axel petzold

  165. Cerebrospinal fluid ATP metabolites in multiple sclerosis

    Article • Multiple Sclerosis Journal, March 2010, SAGE Publications

    Mr axel petzold

  166. A highly sensitive electrochemiluminescence immunoassay for the neurofilament heavy chain protein

    Article • Journal of Neuroimmunology, March 2010, Elsevier

    Mr axel petzold

  167. Recurrent ptosis due to myopathy of the levator palpebrae superioris

    Article • Journal of Neurology Neurosurgery & Psychiatry, February 2010, BMJ

    Mr axel petzold

  168. Konsensusprotokoll zur Standardisierung von Entnahme und Biobanking des Liquor cerebrospinalis / A consensus protocol for the standardisation of cerebrospinal fluid collection and biobanking

    Article • LaboratoriumsMedizin, February 2010, De Gruyter

    Mr axel petzold

  169. Neurology training around the world: asking the trainees

    Article • The Lancet Neurology, January 2010, Elsevier

    Mr axel petzold

  170. Neurofilament ELISA validation

    Article • Journal of Immunological Methods, January 2010, Elsevier

    Mr axel petzold, Professor Robert Weissert, prof aksel siva

  171. Short commentary on ‘a consensus protocol for the standardization of cerebrospinal fluid collection and biobanking’

    Article • Multiple Sclerosis Journal, December 2009, SAGE Publications

    Mr axel petzold

  172. Neuromyelitis optica-IgG (aquaporin-4) autoantibodies in immune mediated optic neuritis

    Article • Journal of Neurology Neurosurgery & Psychiatry, December 2009, BMJ

    Mr axel petzold

  173. A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking

    Article • Neurology, November 2009, Wolters Kluwer Health

    Mr axel petzold

  174. Synchronised Paroxysmal Ocular Tilt Reaction and Limb Dystonia

    Article • Neuro-Ophthalmology, October 2009, Taylor & Francis

    Mr axel petzold

  175. Neuronal and glial cerebrospinal fluid protein biomarkers are elevated after West Nile Virus infection

    Article • Muscle & Nerve, September 2009, Wiley

    Mr axel petzold

  176. Synchronised Paroxysmal Ocular Tilt Reaction and Limb Dystonia

    Article • Neuro-Ophthalmology, September 2009, Taylor & Francis

    Mr axel petzold

  177. A novel biomarker for retinal degeneration: vitreous body neurofilament proteins

    Article • Journal of Neural Transmission, September 2009, Springer Science + Business Media

    Mr axel petzold

  178. Cerebrospinal fluid biomarkers in multiple sclerosis

    Article • Neurobiology of Disease, August 2009, Elsevier

    Mr axel petzold

  179. The Longitudinal Profile of Bilirubin and Ferritin in the Cerebrospinal Fluid Following a Subarachnoid Hemorrhage: Diagnostic Implications

    Article • Neurocritical Care, July 2009, Springer Science + Business Media

    Mr axel petzold

  180. Increase of uric acid and purine compounds in biological fluids of multiple sclerosis patients

    Article • Clinical Biochemistry, July 2009, Elsevier

    Mr axel petzold

  181. The longitudinal profile of CSF markers during external lumbar drainage

    Article • Journal of Neurology Neurosurgery & Psychiatry, June 2009, BMJ

    Mr axel petzold

  182. CSF protein biomarkers for proximal axonal damage improve prognostic accuracy in the acute phase of Guillain-Barré syndrome

    Article • Muscle & Nerve, June 2009, Wiley

    Mr axel petzold

  183. Improving the recovery of S100B protein in cerebral microdialysis: Implications for multimodal monitoring in neurocritical care

    Article • Journal of Neuroscience Methods, June 2009, Elsevier

    Mr axel petzold

  184. EFNS guidelines on disease-specific CSF investigations

    Article • European Journal of Neurology, June 2009, Wiley

    Mr axel petzold

  185. The Value of the Serum Neurofilament Protein Heavy Chain as a Biomarker for Peri-operative Brain Injury After Carotid Endarterectomy

    Article • Neurochemical Research, May 2009, Springer Science + Business Media

    Mr axel petzold

  186. Glial fibrillary acidic protein in Guillain-Barré syndrome: Methodological issues

    Article • Muscle & Nerve, April 2009, Wiley

    Mr axel petzold

  187. A worldwide multicentre comparison of assays for cerebrospinal fluid biomarkers in Alzheimer's disease

    Article • Annals of Clinical Biochemistry International Journal of Laboratory Medicine, April 2009, SAGE Publications

    Mr axel petzold

  188. Longitudinal one-year study of levels and stoichiometry of neurofilament heavy and light chain concentrations in CSF in patients with multiple system atrophy

    Article • Journal of the Neurological Sciences, April 2009, Elsevier

    Mr axel petzold

  189. The Historical Origin of the Pulfrich Effect: A Serendipitous Astronomic Observation at the Border of the Milky Way

    Article • Neuro-Ophthalmology, January 2009, Taylor & Francis

    Mr axel petzold

  190. Cerebrospinal fluid biomarkers in Guillain-Barré syndrome – Where do we stand?

    Article • Journal of Neurology, January 2009, Springer Science + Business Media

    Mr axel petzold

  191. Isolated, relapsing and progressive demyelinating diseases of the central nervous system

    Article • Journal of Neurology, December 2008, Springer Science + Business Media

    Mr axel petzold

  192. Phosphorylation and compactness of neurofilaments in multiple sclerosis: Indicators of axonal pathology

    Article • Experimental Neurology, October 2008, Elsevier

    Mr axel petzold

  193. Glial and Axonal Body Fluid Biomarkers Are Related to Infarct Volume, Severity, and Outcome

    Article • Journal of Stroke and Cerebrovascular Diseases, July 2008, Elsevier

    Mr axel petzold

  194. Metabolic failure precedes intracranial pressure rises in traumatic brain injury: a microdialysis study

    Article • Acta Neurochirurgica, April 2008, Springer Science + Business Media

    Mr axel petzold

  195. Cerebrospinal fluid brain specific proteins in relation to nitric oxide metabolites during relapse of multiple sclerosis

    Article • Multiple Sclerosis Journal, January 2008, SAGE Publications

    Mr axel petzold

  196. Marathon related death due to brainstem herniation in rehydration-related hyponatraemia: a case report

    Article • Journal of Medical Case Reports, December 2007, Springer Science + Business Media

    Mr axel petzold

  197. Assessing visual fields for driving in patients with paracentral scotomata

    Article • British Journal of Ophthalmology, October 2007, BMJ

    Mr axel petzold

  198. CSF biomarkers for improved prognostic accuracy in acute CNS disease

    Article • Neurological Research, October 2007, Taylor & Francis

    Mr axel petzold

  199. Plasma neurofilament heavy chain levels in Huntington's disease

    Article • Neuroscience Letters, May 2007, Elsevier

    Mr axel petzold

  200. Astrocytic activation in relation to inflammatory markers during clinical exacerbation of relapsing-remitting multiple sclerosis

    Article • Journal of Neural Transmission, March 2007, Springer Science + Business Media

    Mr axel petzold, Waldemar Turski

  201. High CSF neurofilament heavy chain levels in neuromyelitis optica

    Article • Neurology, March 2007, Wolters Kluwer Health

    Mr axel petzold

  202. Comparison of two ELISA methods for measuring levels of the phosphorylated neurofilament heavy chain

    Article • Journal of Immunological Methods, January 2007, Elsevier

    Mr axel petzold

  203. CSF Neurofilaments in Frontotemporal Dementia Compared with Early Onset Alzheimer’s Disease and Controls

    Article • Dementia and Geriatric Cognitive Disorders, January 2007, Karger Publishers

    Mr axel petzold

  204. A Systematic Review and Meta-Analysis of CSF Neurofilament Protein Levels as Biomarkers in Dementia

    Article • Neurodegenerative Diseases, January 2007, Karger Publishers

    Mr axel petzold

  205. H2O Coma

    Article • Neurocritical Care, January 2007, Springer Science + Business Media

    Mr axel petzold

  206. Increased urinary excretion of nitric oxide metabolites in longitudinally monitored migraine patients

    Article • European Journal of Neurology, December 2006, Wiley

    Mr axel petzold

  207. CSF neurofilament levels: A potential prognostic marker in Guillain-Barre syndrome

    Article • Neurology, September 2006, Wolters Kluwer Health

    Mr axel petzold

  208. Brain Extracellular Fluid Nitrite/Nitrate Levels after Traumatic Brain Injury are Related to Survival

    Article • Neurosurgery, August 2006, Wolters Kluwer Health

    Mr axel petzold

  209. Early Identification of Secondary Brain Damage in Subarachnoid Hemorrhage: A Role for Glial Fibrillary Acidic Protein

    Article • Journal of Neurotrauma, July 2006, Mary Ann Liebert Inc

    Mr axel petzold

  210. Axonal damage and outcome in subarachnoid haemorrhage

    Article • Journal of Neurology Neurosurgery & Psychiatry, June 2006, BMJ

    Mr axel petzold

  211. The new Global Multiple Sclerosis Severity Score (MSSS) correlates with axonal but not glial biomarkers

    Article • Multiple Sclerosis Journal, June 2006, SAGE Publications

    Mr axel petzold

  212. Clinical disorders affecting mesopic vision

    Article • Ophthalmic and Physiological Optics, May 2006, Wiley

    Mr axel petzold

  213. Axonal damage markers in the cerebrospinal fluid of patients with clinically isolated syndrome improve predicting conversion to definite multiple sclerosis

    Article • Multiple Sclerosis Journal, April 2006, SAGE Publications

    Mr axel petzold

  214. Axonal damage markers in cerebrospinal fluid are increased in ALS

    Article • Neurology, March 2006, Wolters Kluwer Health

    Mr axel petzold

  215. Measurement of high affinity antibodies on antigen-immunoblots

    Article • Journal of Immunological Methods, March 2006, Elsevier

    Mr axel petzold

  216. High Intracranial Pressure, Brain Herniation and Death in Cerebral Venous Thrombosis

    Article • Stroke, February 2006, Wolters Kluwer Health

    Mr axel petzold

  217. Extracellular N-acetylaspartate depletion in traumatic brain injury

    Article • Journal of Neurochemistry, February 2006, Wiley

    Mr axel petzold

  218. Neurofilament heavy-chain NfHSMI35 in cerebrospinal fluid supports the differential diagnosis of Parkinsonian syndromes

    Article • Movement Disorders, January 2006, Wiley

    Mr axel petzold

  219. Free phenytoin concentration measurement in brain extracellular fluid: a pilot study

    Article • British Journal of Neurosurgery, January 2006, Taylor & Francis

    Mr axel petzold

  220. The Neurofilament Heavy Chain (NfHSMI35) in the Cerebrospinal Fluid Diagnosis of Alzheimer’s Disease

    Article • Dementia and Geriatric Cognitive Disorders, January 2006, Karger Publishers

    Mr axel petzold

  221. Educational Approach on Stroke Training in Europe

    Article • Clinical and Experimental Hypertension, January 2006, Taylor & Francis

    Mr axel petzold, Dr. Nicola Tambasco

  222. Spectrophotometry for Cerebrospinal Fluid Pigment Analysis

    Article • Neurocritical Care, January 2006, Springer Science + Business Media

    Mr axel petzold

  223. Amniotic fluid brain-specific proteins are biomarkers for spinal cord injury in experimental myelomeningocele

    Article • Journal of Neurochemistry, October 2005, Wiley

    Mr axel petzold

  224. Optic flow induced nystagmus

    Article • Journal of Neurology Neurosurgery & Psychiatry, August 2005, BMJ

    Mr axel petzold

  225. No evidence for MSRV viraemia and glial cell death in acute optic neuritis

    Article • Multiple Sclerosis Journal, August 2005, SAGE Publications

    Mr axel petzold

  226. Neurofilament phosphoforms: Surrogate markers for axonal injury, degeneration and loss

    Article • Journal of the Neurological Sciences, June 2005, Elsevier

    Mr axel petzold

  227. Critical Illness Brain Syndrome (CIBS): An Underestimated Entity?

    Article • Critical Care Medicine, June 2005, Wolters Kluwer Health

    Mr axel petzold

  228. Why Human Color Vision Cannot Reliably Detect Cerebrospinal Fluid Xanthochromia

    Article • Stroke, May 2005, Wolters Kluwer Health

    Mr axel petzold

  229. Extracellular fluid S100B in the injured brain: a future surrogate marker of acute brain injury?

    Article • Acta Neurochirurgica, April 2005, Springer Science + Business Media

    Mr axel petzold

  230. The Bryan cervical disc prosthesis as an alternative to arthrodesis in the treatment of cervical spondylosis: 46 CONSECUTIVE CASES

    Article • Journal of Bone and Joint Surgery - British Volume, April 2005, Bone & Joint

    Mr axel petzold

  231. Decreased CSF hypocretin-1 (orexin-A) after acute haemorrhagic brain injury

    Article • Journal of Neurology Neurosurgery & Psychiatry, April 2005, BMJ

    Mr axel petzold

  232. Axonal Pathology in Subarachnoid and Intracerebral Hemorrhage

    Article • Journal of Neurotrauma, March 2005, Mary Ann Liebert Inc

    Mr axel petzold

  233. Axonal damage accumulates in the progressive phase of multiple sclerosis: three year follow up study

    Article • Journal of Neurology Neurosurgery & Psychiatry, February 2005, BMJ

    Mr axel petzold

  234. The pro and the active form of matrix metalloproteinase-9 is increased in serum of patients with amyotrophic lateral sclerosis

    Article • Journal of Neuroimmunology, February 2005, Elsevier

    Mr axel petzold

  235. Central and Paracentral Visual Field Defects and Driving Abilities

    Article • Ophthalmologica, January 2005, Karger Publishers

    Mr axel petzold

  236. Spectrophotometry for Xanthochromia

    Article • New England Journal of Medicine, October 2004, New England Journal of Medicine (NEJM/MMS)

    Mr axel petzold

  237. Serum S100B in primary progressive multiple sclerosis patients treated with interferon-beta-1a

    Article • Journal of Negative Results in BioMedicine, October 2004, Springer Science + Business Media

    Mr axel petzold

  238. Axonal degeneration and inflammation in acute optic neuritis

    Article • Journal of Neurology Neurosurgery & Psychiatry, August 2004, BMJ

    Mr axel petzold

  239. Transient monocular blindness: the controversial role of the ophthalmic artery

    Article • Journal of Neurology, July 2004, Springer Science + Business Media

    Mr axel petzold

  240. Treatment response in relation to inflammatory and axonal surrogate marker in multiple sclerosis

    Article • Multiple Sclerosis Journal, June 2004, SAGE Publications

    Mr axel petzold

  241. Cerebrospinal fluid nitrite/nitrate correlated with oxyhemoglobin and outcome in patients with subarachnoid hemorrhage

    Article • Journal of the Neurological Sciences, April 2004, Elsevier

    Mr axel petzold

  242. An ELISA for glial fibrillary acidic protein

    Article • Journal of Immunological Methods, April 2004, Elsevier

    Mr axel petzold

  243. Temporal Alterations in Cerebrospinal Fluid Amyloid  -Protein and Apolipoprotein E After Subarachnoid Hemorrhage

    Article • Stroke, November 2003, Wolters Kluwer Health

    Mr axel petzold

  244. Triple-H therapy in the management of aneurysmal subarachnoid haemorrhage

    Article • The Lancet Neurology, October 2003, Elsevier

    Mr axel petzold

  245. Alterations in Cerebrospinal Fluid Apolipoprotein E and Amyloid β -Protein after Traumatic Brain Injury

    Article • Journal of Neurotrauma, October 2003, Mary Ann Liebert Inc

    Mr axel petzold

  246. Cerebrospinal fluid (CSF) and serum S100B: release and wash-out pattern

    Article • Brain Research Bulletin, August 2003, Elsevier

    Mr axel petzold

  247. A specific ELISA for measuring neurofilament heavy chain phosphoforms

    Article • Journal of Immunological Methods, July 2003, Elsevier

    Mr axel petzold

  248. Cannabinoids inhibit neurodegeneration in models of multiple sclerosis

    Article • Brain, June 2003, Oxford University Press (OUP)

    Mr axel petzold

  249. Quantification of neurodegeneration by measurement of brain-specific proteins

    Article • Journal of Neuroimmunology, May 2003, Elsevier

    Mr axel petzold

  250. Impaired fibrinolysis in multiple sclerosis: a role for tissue plasminogen activator inhibitors

    Article • Brain, April 2003, Oxford University Press (OUP)

    Mr axel petzold

  251. Video Reconstruction of Vasospastic Transient Monocular Blindness

    Article • New England Journal of Medicine, April 2003, New England Journal of Medicine (NEJM/MMS)

    Mr axel petzold

  252. Serum and urine nitrate and nitrite are not reliable indicators of intrathecal nitric oxide production in acute brain injury

    Article • Journal of the Neurological Sciences, April 2003, Elsevier

    Mr axel petzold

  253. Cerebrospinal Fluid Apolipoprotein E Concentration Decreases after Traumatic Brain Injury

    Article • Journal of Neurotrauma, March 2003, Mary Ann Liebert Inc

    Mr axel petzold

  254. Decreased Cerebrospinal Fluid Apolipoprotein E After Subarachnoid Hemorrhage: Correlation With Injury Severity and Clinical Outcome

    Article • Stroke, February 2003, Wolters Kluwer Health

    Mr axel petzold

  255. Multiple sclerosis: Neurofilament light chain antibodies are correlated to cerebral atrophy

    Article • Neurology, January 2003, Wolters Kluwer Health

    Mr axel petzold

  256. Cerebrospinal fluid S100B correlates with brain atrophy in Alzheimer's disease

    Article • Neuroscience Letters, January 2003, Elsevier

    Mr axel petzold

  257. Role of serum S100B as an early predictor of high intracranial pressure and mortality in brain injury: A pilot study

    Article • Critical Care Medicine, December 2002, Wolters Kluwer Health

    Mr axel petzold

  258. Media Watch

    Article • The Lancet Neurology, November 2002, Elsevier

    Mr axel petzold

  259. Markers for different glial cell responses in multiple sclerosis: clinical and pathological correlations

    Article • Brain, July 2002, Oxford University Press (OUP)

    Mr axel petzold

  260. Rapidly developing intimal fibrosis mimicking giant cell arteritis

    Article • British Journal of Ophthalmology, January 2002, BMJ

    Mr axel petzold

  261. Dense Kayser-Fleischer ring in asymptomatic Wilson's disease (hepatolenticular degeneration)

    Article • British Journal of Ophthalmology, January 2002, BMJ

    Mr axel petzold

  262. Relapsing intracranial Rosai-Dorfman disease

    Article • Journal of Neurology Neurosurgery & Psychiatry, October 2001, BMJ

    Mr axel petzold

  263. Recurrent ptosis

    Article • Journal of Neurology Neurosurgery & Psychiatry, June 2001, BMJ

    Mr axel petzold

  264. Recurrent ptosis in an adult due to isolated paresis of the levator palpebrae superioris and M�ller?s muscle of unknown aetiology

    Article • Neuro-Ophthalmology, August 2000, Swets & Zeitlinger Publishers

    Mr axel petzold

  265. Repetitive cerebral bleeding in an adult with Klippel-Trénaunay Syndrome

    Article • Journal of Neurology, May 2000, Springer Science + Business Media

    Mr axel petzold

  266. Failure to detect bitemporal field defects due to chiasmal compression on a screening perimetry protocol

    Article • Neuro-Ophthalmology, January 2000, Swets & Zeitlinger Publishers

    Mr axel petzold

  267. Hue memory and discrimination in young children

    Article • Vision Research, December 1998, Elsevier

    Mr axel petzold

  268. Neuronal Cell Death and Axonal Degeneration: Neurofilaments as Biomarkers

    Article • Springer Science + Business Media

    Mr axel petzold